Day One Biopharmaceuticals
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$703,048
Doctors Paid
101
Transactions
441
2024 Total
$703,048
Payment Breakdown by Category
Research$511,343 (72.7%)
Consulting$116,615 (16.6%)
Travel$15,829 (2.3%)
Food & Beverage$5,951 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $511,343 | 250 | 72.7% |
| Consulting Fee | $116,615 | 32 | 16.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,310 | 15 | 7.2% |
| Travel and Lodging | $15,829 | 30 | 2.3% |
| Food and Beverage | $5,951 | 113 | 0.8% |
| Space rental or facility fees (teaching hospital only) | $3,000 | 1 | 0.4% |
Payments by Type
Research
$511,343
250 transactions
General
$191,705
191 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase 1b/2, Open Label Study of DAY101 Monotherapy or Combination with Other Therapies for Patients with Recurrent, Progressive, or Refractory Solid Tumors Harboring MAPK Pathway Aberrations | $313,784 | 0 | 121 |
| DAY101-001/PNOC026: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors | $131,823 | 0 | 105 |
| LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients With Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy | $65,736 | 0 | 24 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Pediatric Hematology-Oncology | $83,510 | 37 | $2,257 |
| Pediatrics | $35,287 | 28 | $1,260 |
| Student in an Organized Health Care Education/Training Program | $32,977 | 8 | $4,122 |
| Anesthesiology | $17,738 | 1 | $17,738 |
| Neurology | $9,310 | 3 | $3,103 |
| Medical Oncology | $3,150 | 1 | $3,150 |
| Ophthalmology | $2,880 | 1 | $2,880 |
| Pediatric Dermatology | $2,600 | 1 | $2,600 |
| Nurse Practitioner | $287.49 | 4 | $71.87 |
| Medical | $236.53 | 2 | $118.27 |
| Psychiatric/Mental Health | $124.99 | 1 | $124.99 |
| Anatomic Pathology & Clinical Pathology | $121.21 | 1 | $121.21 |
| Critical Care Medicine | $115.32 | 1 | $115.32 |
| Neurological Surgery | $115.32 | 1 | $115.32 |
| Hematology & Oncology | $65.64 | 3 | $21.88 |
| Family Medicine | $46.80 | 2 | $23.40 |
| Internal Medicine | $41.19 | 2 | $20.60 |
| Primary Care | $28.93 | 1 | $28.93 |
| Pediatric Oncology | $27.57 | 1 | $27.57 |
| Family | $23.40 | 1 | $23.40 |
| Specialist | $20.03 | 1 | $20.03 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Caroline Hastings, Md, MD | Pediatric Hematology-Oncology | Oakland, CA | $34,246 | $0 |
| Dr. Daniel Landi, M.d, M.D | Student in an Organized Health Care Education/Training Program | Durham, NC | $27,934 | $0 |
| Dr. Amy Smith, Md, MD | Pediatric Hematology-Oncology | Cleveland, OH | $20,091 | $0 |
| Bridget Archambault, Np, NP | Anesthesiology | Durham, NC | $17,738 | $0 |
| Dr. Mohamed Abdelbaki, Md, MD | Pediatrics | Saint Louis, MO | $9,210 | $0 |
| Betty Herrington, Md, MD | Pediatric Hematology-Oncology | Jackson, MS | $6,546 | $0 |
| Dr. Ashley Margol, Md, MD | Pediatrics | Los Angeles, CA | $5,525 | $0 |
| Robert Avery, Do, DO | Neurology | Philadelphia, PA | $4,500 | $0 |
| Michael Levine, Md, MD | Pediatrics | Philadelphia, PA | $3,500 | $0 |
| Ms. Corrine Hoeppner, Arnp, ARNP | Pediatrics | Seattle, WA | $3,233 | $0 |
| Murali Chintagumpala, Md, MD | Pediatric Hematology-Oncology | Houston, TX | $3,201 | $0 |
| Stewart Goldman, Md, MD | Pediatric Hematology-Oncology | Chicago, IL | $3,195 | $0 |
| Tobey Macdonald, Md, MD | Pediatric Hematology-Oncology | Washington, DC | $3,195 | $0 |
| Nathan Robison, Md, MD | Pediatric Hematology-Oncology | Los Angeles, CA | $3,150 | $0 |
| Kenneth Cohen, M.d, M.D | Medical Oncology | Baltimore, MD | $3,150 | $0 |
| Andrea Franson, Md, MD | Pediatrics | Ann Arbor, MI | $3,075 | $0 |
| Aparna Ramasubramanian, M.d, M.D | Ophthalmology | Milwaukee, WI | $2,880 | $0 |
| Jessica Clymer | Pediatric Hematology-Oncology | Boston, MA | $2,725 | $0 |
| Dr. Nicole Ullrich, Md, MD | Neurology | Boston, MA | $2,680 | $0 |
| Richard Drachtman | Pediatrics | New Brunswick, NJ | $2,600 | $0 |
| Dr. Karina Vivar, Md, MD | Pediatric Dermatology | Chicago, IL | $2,600 | $0 |
| Dr. Trisha Larkin, M.d, M.D | Student in an Organized Health Care Education/Training Program | Tampa, FL | $2,571 | $0 |
| Mrs. Megan Paul, M.d, M.D | Pediatrics | San Diego, CA | $2,475 | $0 |
| Dr. Adriana Fonseca Sheridan, Md, MD | Pediatric Hematology-Oncology | Washington, DC | $2,460 | $0 |
| Dr. Scott Coven, D.o, D.O | Pediatrics | Indianapolis, IN | $2,400 | $0 |
About Day One Biopharmaceuticals
Day One Biopharmaceuticals has made $703,048 in payments to 101 healthcare providers, recorded across 441 transactions in the CMS Open Payments database. In 2024, the company paid $703,048. The top product by payment volume is OJEMDA ($703,048).
Payments were distributed across 21 medical specialties. The top specialty by payment amount is Pediatric Hematology-Oncology ($83,510 to 37 doctors).
Payment categories include: Food & Beverage ($5,951), Consulting ($116,615), Research ($511,343), Travel & Lodging ($15,829).
Day One Biopharmaceuticals is associated with 1 products in the CMS Open Payments database.